Systemic delivery of anti-HGF-neutralizing monoclonal antibody downregulates C-met signaling pathways in glioma xenografts

被引:0
|
作者
Lal, Bachchu
Gerber, David E.
Kim, Jin
Laterra, John
机构
[1] Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD USA
[2] Galaxy Biotech Inc, Mountain View, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:415 / 415
页数:1
相关论文
共 27 条
  • [1] Systemic delivery of anti-HGF monoclonal antibody inhibits glioma growth through downstream oncogenic signaling molecules
    Cornet, K.
    Lal, B.
    Goodwin, C. R.
    Laterra, J.
    PLANTA MEDICA, 2008, 74 (03) : 334 - 334
  • [2] ONARTUZUMAB Anti-HGFR (c-Met) monoclonal antibody Oncolytic
    Arriola, E.
    Conde-Estevez, D.
    DRUGS OF THE FUTURE, 2014, 39 (06) : 403 - 408
  • [3] Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621
    Michaud, Neil R.
    Jani, Jitesh P.
    Hillerman, Stephen
    Tsaparikos, Konstantinos E.
    Barbacci-Tobin, Elsa G.
    Knauth, Elisabeth
    Putz, Henry, Jr.
    Campbell, Mary
    Karam, George A.
    Chrunyk, Boris
    Gebhard, David F.
    Green, Larry L.
    Xu, Jinghai J.
    Dunn, Margaret C.
    Coskran, Tim M.
    Lapointe, Jean-Martin
    Cohen, Bruce D.
    Coleman, Kevin G.
    Bedian, Vahe
    Vincent, Patrick
    Kajiji, Shama
    Steyn, Stefan J.
    Borzillo, Gary V.
    Los, Gerrit
    MABS, 2012, 4 (06) : 710 - 723
  • [4] Systemic anti-HGF monoclonal antibody therapy induces regression of intracranial glioma xenograft
    Kim, K. Jin
    Wang, Lihong
    Su, Yi-Chi
    Gillespie, G. Yancey
    Salhotra, Amandeep
    CANCER RESEARCH, 2006, 66 (08)
  • [5] Targeting the c-Met signaling pathway by humanized anti-HGF antibody inhibits irinotecan resistance in colorectal cancer.
    Woo, Jong Kyu
    Jang, Yeong-Su
    Kang, Ju-Hee
    Kim, Hwan Mook
    Oh, Seung-Hyun
    CANCER RESEARCH, 2015, 75 (01)
  • [6] Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells
    Huang, Kuo-Hung
    Sung, I-Cheng
    Fang, Wen-Liang
    Chi, Chin-Wen
    Yeh, Tien-Shun
    Lee, Hsin-Chen
    Yin, Pen-Hui
    Li, Anna Fen-Yau
    Wu, Chew-Wun
    Shyr, Yi-Ming
    Yang, Muh-Hwa
    ONCOLOGY REPORTS, 2018, 40 (01) : 294 - 302
  • [7] Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts
    Kim, KJ
    Wang, LH
    Su, YC
    Gillespie, GY
    Salhotra, A
    Lal, B
    Laterra, J
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1292 - 1298
  • [8] Inhibiting SF/HGF and c-MET expression with U1snRNA/ribozymes markedly enhances the radiotherapeutic response in human glioma xenografts
    Lal, B
    Xia, S
    Abounader, R
    Laterra, J
    NEURO-ONCOLOGY, 2004, 6 (04) : 332 - 333
  • [9] Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c-met/HGF and its associated downstream signaling pathways
    Jung, Young Yun
    Um, Jae-Young
    Sethi, Gautam
    Ahn, Kwang Seok
    PHYTOTHERAPY RESEARCH, 2022, 36 (12) : 4542 - 4557
  • [10] Inhibiting endothelium directed tumor cell streaming by targeting the HGF/C-Met and EGF/CSF-1 signaling pathways
    Leung, Edison
    Wang, Yarong
    Smith, Bryan
    Flynn, Daniel
    Condeelis, John
    CANCER RESEARCH, 2015, 75